Innovent Biologics announced that its GLP-1 drug, Mazdutide (6 mg), achieved better results than Novo Nordisk’s Semaglutide (1 mg) in a study involving patients with type 2 diabetes and obesity. In the DREAMS-3 trial, Mazdutide reduced HbA1C by an average of 2.03% compared to 1.84% for Semaglutide, and patients lost 10.29% of body weight versus 6% with Ozempic.
New research from the University of Cambridge and Meta Reality Labs, published in Nature Communications, sheds light on how much the human eye can truly perceive — and suggests that in many cases, 4K and 8K resolutions in TVs are unnecessary.
The Australian Competition and Consumer Commission (ACCC) has filed a lawsuit against Microsoft Corporation in federal court, accusing the company of misleading around 2.7 million Australian users of Microsoft 365 regarding price hikes and the integration of its AI tool, Copilot.
Reddit has filed a lawsuit against Perplexity AI and three other companies, accusing them of industrial-scale data scraping — the unauthorized collection and use of Reddit users’ posts and comments to train AI systems, despite prior cease-and-desist notices.